SOX2 and urogenital neoplasm: In our study, we demonstrated a significant higher percentage of SOX2 positive cells in prostate cancer compared with prostatitis and BPH lesions; however, Ugolkov et al., (2011) reported an increase in expression of SOX2 in both benign and malignant prostate tissue, but only in a small percentage of cells (10%).